linkedin

About
Samsung Biologics

With proven regulatory approvals, the largest single site capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to provide seamless offerings from development, manufacturing, to laboratory testing services at every stage for biopharmaceutical products while meeting the evolving needs of the global healthcare industry.

Our Vision

To enrich human life with
technology and innovation

Our Mission and
Innovation Strategy

By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for humanity through biomedicines.

3PInnovation

At Samsung Biologics, our innovation starts with the best People, specifically “Pi Type” people who are not only rooted in more than one field of expertise, but also with the ability to span their influence across the organization.

We invest in our People to develop Talent and demonstrate our core Values. We believe that attaining Knowledge builds Expertise, and combined with Creativity and strong Teamwork, we can achieve consistent Execution of our mission, all the while living our core values of Humanity, Integrity, Passion, Ownership and Dedication to each other, our clients, and to society.

Our People innovation is also the foundation upon which our other core innovation principles are built.

Process Innovation is how we ensure the highest quality by striving beyond “good” to “best” manufacturing practices through client-centric innovation. Our execution excellence is enhanced by our agility, adaptability, and speed in responding to changing global business conditions, resulting in cost competitiveness for the benefit of our clients and for patient access to life saving drugs.

Portfolio Innovation drives us to continuously expand our business scope and breadth of services beyond CMO to CDO and CRO, establishing global reach and proximity to our clients to offer fully integrated end-to-end services across an ever expanding diversified business portfolio, resulting in a highly maximized, “Super Value” for our shareholders and clients.

The ultimate purpose of our People, Process, and Portfolio Innovation is to support our Clients and become their most trusted partner in the mission to improving human lives through biomedicines.

We call this concept our “3P Innovation Chain” which is embedded in our business DNA – By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our Clients in achieving Better Life for humanity through biomedicines.

Choosing Samsung means choosing better. Better life-giving biologics for "Better Life."

Better Life with Samsung Biologics.

People

We invest in our people to develop talents and demonstrate our core values. We believe that attaining knowledge builds expertise, and combined with creativity and strong teamwork, we can achieve consistent execution of our mission, all the while living our core values of humanity, integrity, passion, ownership, and dedication to each other, our clients, and to society.

Talents
  • Knowledge
  • Expertise
  • Creativity
  • Teamwork
  • Execution
Values
  • Humanity
  • Integrity
  • Passion
  • Ownership
  • Dedication

Process

Process Innovation is how we ensure the highest quality by striving beyond “good” to “best” manufacturing practices through client-centric innovation. Our execution excellence is enhanced by our agility, adaptability, and speed in responding to changing global business conditions, resulting in cost competitiveness to the benefit of our clients and for patient access to life-saving drugs.

  • Highest Quality
  • Best Manufacturing Practices
  • Client-centric Innovation
  • Agility, Adaptability, Speed
  • Cost Competitiveness
  • Highest Quality
  • Best Manufacturing Practices
  • Client-centric Innovation
  • Agility, Adaptability, Speed
  • Cost Competitiveness

Portfolio

Portfolio Innovation drives us to continuously expand our business scope and breadth of services beyond CMO to CDO and CRO, establishing global reach and proximity to our clients to offer fully integrated end-to-end services across an ever expanding diversified business portfolio, resulting in a highly maximized, “Super Value” for our shareholders and clients.

  • CMO, CDO, CRO
  • Global Presence
  • Integrated Services
  • Business Diversification
  • Super Value for Shareholders
  • CMO, CDO, CRO
  • Global Presence
  • Integrated Services
  • Business Diversification
  • Super Value for Shareholders

SITE MAP

close
Close

Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.

Close

Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved